Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study
- PMID: 21376537
- PMCID: PMC3691956
- DOI: 10.1016/j.schres.2011.02.003
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study
Figures
References
-
- Himelhoch S, Daumit G. To whom do psychiatrists offer smoking-cessation counseling? Am J Psychiatry. 2003;160(12):2228–2230. - PubMed
-
- Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. - PubMed
-
- U.S. Food and Drug Administration . Public Health Advisory: Important Information on Chantix (varenicline) U S Food and Drug Administration, Center for Drug Evaluation and Research; [Accessed May 4, 2008]. Feb 1, 2008. http://www.fda.gov/cder/drug/advisory/varenicline.htm.
-
- Freedman R. Exacerbation of schizophrenia by varenicline. Am J Psychiatry. 2007 Aug;164(8):1269. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
